KR100351534B1 - 헬리코박터감염의치료또는예방용항원제제 - Google Patents

헬리코박터감염의치료또는예방용항원제제 Download PDF

Info

Publication number
KR100351534B1
KR100351534B1 KR1019960704542A KR19960704542A KR100351534B1 KR 100351534 B1 KR100351534 B1 KR 100351534B1 KR 1019960704542 A KR1019960704542 A KR 1019960704542A KR 19960704542 A KR19960704542 A KR 19960704542A KR 100351534 B1 KR100351534 B1 KR 100351534B1
Authority
KR
South Korea
Prior art keywords
helicobacter
lps
treatment
infection
vaccine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019960704542A
Other languages
English (en)
Korean (ko)
Other versions
KR970701209A (ko
Inventor
빈센트 도이지 크리스토퍼
리 애드리언
제인 벅 피오나
알렉산더 퀸 찰스
조지 바 이언
존 클레이닉 마이클
피트르자이코프스키 엘리자베스
Original Assignee
시에스엘 리미티드
더 유니버시티 오브 뉴 사우스 웨일즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시에스엘 리미티드, 더 유니버시티 오브 뉴 사우스 웨일즈 filed Critical 시에스엘 리미티드
Publication of KR970701209A publication Critical patent/KR970701209A/ko
Application granted granted Critical
Publication of KR100351534B1 publication Critical patent/KR100351534B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
KR1019960704542A 1994-02-21 1995-02-17 헬리코박터감염의치료또는예방용항원제제 Expired - Fee Related KR100351534B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM3995 1994-02-21
AUPM3995A AUPM399594A0 (en) 1994-02-21 1994-02-21 Antigenic preparation for treatment or prevention of helicobacter infection

Publications (2)

Publication Number Publication Date
KR970701209A KR970701209A (ko) 1997-03-17
KR100351534B1 true KR100351534B1 (ko) 2003-03-15

Family

ID=3778612

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960704542A Expired - Fee Related KR100351534B1 (ko) 1994-02-21 1995-02-17 헬리코박터감염의치료또는예방용항원제제

Country Status (10)

Country Link
US (1) US6663873B2 (cg-RX-API-DMAC10.html)
EP (1) EP0804489B1 (cg-RX-API-DMAC10.html)
JP (1) JPH10500102A (cg-RX-API-DMAC10.html)
KR (1) KR100351534B1 (cg-RX-API-DMAC10.html)
AT (1) ATE222930T1 (cg-RX-API-DMAC10.html)
AU (2) AUPM399594A0 (cg-RX-API-DMAC10.html)
CA (1) CA2182274C (cg-RX-API-DMAC10.html)
DE (1) DE69527986T2 (cg-RX-API-DMAC10.html)
NZ (2) NZ281146A (cg-RX-API-DMAC10.html)
WO (1) WO1995022563A1 (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM399594A0 (en) * 1994-02-21 1994-03-17 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection
US5681736A (en) * 1994-10-05 1997-10-28 Antex Biologics, Inc. Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
DK0792347T3 (da) * 1994-10-05 2006-04-03 Emergent Immunosolutions Inc Fremgangsmåder til fremstilling af forbedrede antigene Heliobacter sp. og vacciner omfattende samme
AU693679B2 (en) * 1995-04-21 1998-07-02 Csl Limited Protective helicobacter antigens
CA2217496A1 (en) 1995-04-21 1996-10-24 Csl Limited Protective helicobacter antigens
AU6583398A (en) * 1997-03-26 1998-10-20 Avant Immunotherapeutics, Inc. Polypeptides which immunoreact with polyclonal antisera against (h. pylori)
GB9715702D0 (en) * 1997-07-24 1997-10-01 Univ Bristol Bacterial isolate
US6599509B2 (en) 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
JP4054681B2 (ja) * 2001-02-21 2008-02-27 デンカ生研株式会社 ヘリコバクター・ピロリを認識する抗体、およびヘリコバクター・ピロリを検出する方法
DE102004024674A1 (de) * 2004-05-18 2005-12-15 Wolfgang Lorenz Mittel und Verfahren zur Diagnose, Prophylaxe und Therapie von Bindegewebserkrankungen
WO2007018152A1 (ja) 2005-08-05 2007-02-15 The University Of Tokushima IgA抗体の選択的産生からIgA及びIgG両抗体産生への切換えを可能にする抗原薬物ビークルとこれを用いる経鼻・粘膜ワクチン
PT2945651T (pt) 2013-01-17 2018-06-12 Arsanis Biosciences Gmbh Anticorpo específico para mdr e. coli
CN113388032A (zh) 2014-02-06 2021-09-14 X4制药(奥地利)有限责任公司 大肠杆菌特异性抗体序列
PL3110441T3 (pl) 2014-02-24 2024-08-05 Glaxosmithkline Biologicals S.A. Nowatorski polisacharyd i jego zastosowania
TWI715617B (zh) 2015-08-24 2021-01-11 比利時商葛蘭素史密斯克藍生物品公司 對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物
AR109621A1 (es) 2016-10-24 2018-12-26 Janssen Pharmaceuticals Inc Formulaciones de vacunas contra glucoconjugados de expec
IL286467B1 (en) 2019-03-18 2025-10-01 Janssen Pharmaceuticals Inc Methods for producing bioconjugates of E. COLI O-antigen polysaccharides, preparations thereof and methods for using them
IL286394B2 (en) 2019-03-18 2025-10-01 Janssen Pharmaceuticals Inc E. COLI O-antigen polysaccharide bioconjugates, methods for their production and methods for their use
CN111467368B (zh) * 2020-04-13 2021-05-28 江南大学 含庚糖链的寡糖化合物在制备幽门螺旋杆菌疫苗中的应用
JP7481585B2 (ja) 2020-09-17 2024-05-10 ヤンセン ファーマシューティカルズ，インコーポレーテッド 多価ワクチン組成物及びその使用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022563A1 (en) * 1994-02-21 1995-08-24 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection
KR960700746A (ko) * 1993-07-27 1996-02-24 피터 츄오히 헬리코박터 피롤리 관련 위십이지장 질환의 치료 방법(treatment of h. pylori associated gastroduodenal disease)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644121B2 (en) * 1989-12-04 1993-12-02 Auspharm International Limited Rapid in vitro test for helicobacter pylori using saliva
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
US5098755A (en) * 1990-11-21 1992-03-24 Tanquary Albert C Textured thermoplastic elastomeric film, articles comprising same, and method of making such textured thermoplastic elastomeric film and articles
MX9301706A (es) 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5580563A (en) * 1992-05-01 1996-12-03 Tam; James P. Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
US6406703B1 (en) * 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
US5840302A (en) * 1993-11-10 1998-11-24 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
US5681736A (en) * 1994-10-05 1997-10-28 Antex Biologics, Inc. Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
CA2217496A1 (en) * 1995-04-21 1996-10-24 Csl Limited Protective helicobacter antigens
US5997881A (en) * 1995-11-22 1999-12-07 University Of Maryland, Baltimore Method of making non-pyrogenic lipopolysaccharide or A
AU3458299A (en) * 1998-03-31 1999-10-18 United States Of America, As Represented By The Secretary Of Agriculture, The Monoclonal antibodies against (campylobacter jejuni) and (campylobacter coli) outer membrane antigens
KR20010088302A (ko) * 1998-06-19 2001-09-26 추후 제출 헬리코박터 감염에 대한 비경구 면역화 방법에 있어서의ｌｔ 및 ｃｔ

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960700746A (ko) * 1993-07-27 1996-02-24 피터 츄오히 헬리코박터 피롤리 관련 위십이지장 질환의 치료 방법(treatment of h. pylori associated gastroduodenal disease)
WO1995022563A1 (en) * 1994-02-21 1995-08-24 Csl Limited Antigenic preparation for treatment or prevention of helicobacter infection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
논문(1993.8.) *

Also Published As

Publication number Publication date
CA2182274C (en) 2007-05-22
AUPM399594A0 (en) 1994-03-17
ATE222930T1 (de) 2002-09-15
CA2182274A1 (en) 1995-08-24
NZ329879A (en) 1999-10-28
EP0804489B1 (en) 2002-08-28
WO1995022563A1 (en) 1995-08-24
US20020122794A1 (en) 2002-09-05
JPH10500102A (ja) 1998-01-06
AU1801195A (en) 1995-09-04
KR970701209A (ko) 1997-03-17
DE69527986T2 (de) 2003-04-10
US6663873B2 (en) 2003-12-16
NZ281146A (en) 1998-04-27
EP0804489A4 (cg-RX-API-DMAC10.html) 1997-11-19
AU693864B2 (en) 1998-07-09
HK1004677A1 (en) 1998-12-04
EP0804489A1 (en) 1997-11-05
DE69527986D1 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
KR100351534B1 (ko) 헬리코박터감염의치료또는예방용항원제제
US5538729A (en) Oral treatment of helicobacter infection
Czinn et al. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization
EP0771214B1 (en) Treatment and prevention of helicobacter infection
JPH10505059A (ja) 非毒性口内アジュバントとして有効な突然変異エンテロトキシン
JP2911603B2 (ja) 新規な弱毒化シュードモナス・エルギノーザ株
KR100333113B1 (ko) 헬리코박터피롤리관련위십이지장질환의치료방법
CZ342697A3 (cs) Multimerní rekombinantní ureázová vakcina
JPH11509200A (ja) 粘膜アジュバントとしてのクロストリジウム・ディフィシール（Ｃｌｏｓｔｒｉｄｉｕｍ Ｄｉｆｆｉｃｉｌｅ）トキシン
JP2002518343A (ja) ヘリコバクター感染に対する非経口的免疫処置法におけるｌｔおよびｃｔ
JP3534771B2 (ja) Ｍｏｒａｘｅｌｌａの主要外層膜蛋白ＣＤ
Suckow et al. Oral immunization of rabbits against Pasteurella multocida with an alginate microsphere delivery system
US5089262A (en) E87ag antigens of pseudomonas aeruginosa and monoclonal antibodies against them and hybridomas thereof
US7094391B1 (en) Compositions and methods for administering Borrelia burgdorferi antigens
HK1004677B (en) Antigenic preparation for treatment or prevention of helicobacter infection
AU675938C (en) Oral treatment of helicobacter infection
EP0255755A2 (en) Vaccine preparation
AU702878B2 (en) Treatment and prevention of helicobacter infection
KR100207289B1 (ko) 헬리코박터 파이로리 유래의 항원단백질을 함유하는 리포좀
CA2191440C (en) Treatment and prevention of helicobacter infection
KR100509817B1 (ko) 비브리오불니피쿠스의감염예방을위한경구용백신
EA025417B1 (ru) Вакцины с повышенной иммуногенностью и способы их получения
Buck Vaccine therapy for chronic Helicobacter infection

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20090807

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20100824

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20100824

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000